Advertisement

Topics

InVivo Therapeutics Corporation Company Profile

08:35 EDT 19th September 2018 | BioPortfolio

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD, Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, MD, who is affiliated with Massachusetts General Hospital in Boston.


News Articles [820 Associated News Articles listed on BioPortfolio]

InVivo Therapeutics announces pricing of $13.2M offering

A public stock offering has been priced by InVivo Therapeutics in hopes of raising $13.2 million in gross proceeds.  -More- 

InVivo Therapeutics looks to raise $8M in offering

A registration has been filed by InVivo Therapeutics with the SEC for an offering of shares of common stock and Series A warr -More- 

Offering pulls in about $15.2M for InVivo Therapeutics

A public offering of shares and warrants brought in about $15.2 million for InVivo Therapeutics.  -More- 

FDA OKs second study of InVivo's neuro-spinal scaffold

The FDA has granted InVivo Therapeutics supplemental investigational device exemption approval to conduct a second pivotal st -More- 

InVivo announces reverse stock split, other company updates

A 1-for-25 reverse stock split was announced by InVivo Therapeutics, effective after market closing April 16 -- a move that w -More- 

Offering could pull in about $11M for InVivo Therapeutics

An offering of about 1.5 million shares and 1.5 million Series A warrants has been registered with the Securities and Exchang -More- 

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers

Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partne...

InVivo Therapeutics Announces Pricing of $13.2 Million Underwritten Public Offering

InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of an underwritten public offering of 388,403 shares of its common stock, together with warrants to purchase ...

PubMed Articles [439 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Development and properties of duplex MgF2/PCL coatings on biodegradable magnesium alloy for biomedical applications.

The present work addresses the performance of polycaprolactone (PCL) coating on fluoride treated (MgF2) biodegradable ZK60 magnesium alloy (Mg) for biomedical application. MgF2 conversion layer was fi...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [159 Associated Clinical Trials listed on BioPortfolio]

The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer

This study intends to carry out a prospective, randomized controlled trial to research and development a new invivo microscopy based on the technology which is combined with high-definitio...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1434 Associated Companies listed on BioPortfolio]

InVivo Therapeutics Corporation

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in indiv...

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

InVivo Therapeutics Holding Corporation

InVivo Therapeutics Holding Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function ...

Invivo

Invivo is the pioneer in innovative RF coils to increase image quality and improve diagnostic confidence. We are the world leader in MRI monitoring, providing accurate vital signs for improved patient...

More Information about "InVivo Therapeutics Corporation" on BioPortfolio

We have published hundreds of InVivo Therapeutics Corporation news stories on BioPortfolio along with dozens of InVivo Therapeutics Corporation Clinical Trials and PubMed Articles about InVivo Therapeutics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InVivo Therapeutics Corporation Companies in our database. You can also find out about relevant InVivo Therapeutics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...


Corporate Database Quicklinks



Searches Linking to this Company Record